Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 3 2Phase 2 2Phase NA 1Phase 4 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 113Other hematologic neoplasm 100Plasma cell 47Myeloid 40Sarcoma 18Classical hematology 14CNS 13Breast 13Genitourinary 7Gynecologic 6Thoracic 4Head & Neck 4Gastrointestinal 3Other solid neoplasm 2Dermatologic 2Other 1NET 1Endocrine 1

Conditions

Retinoblastoma 2

Interventions

Cisplatin 42Pemetrexed 31Carboplatin 28Nivolumab 21pembrolizumab 19Gemcitabine 19atezolizumab 13Etoposide 13Injections 12Ipilimumab 11Cyclophosphamide 11Radiotherapy 10Oxaliplatin 10Filgrastim 10Docetaxel 10Bevacizumab 10tislelizumab 9Vincristine 9Specimen Handling 9durvalumab 8Paclitaxel 8Capecitabine 8tremelimumab 7toripalimab 7lenvatinib 7Everolimus 7spartalizumab 6olaparib 6niraparib 6Vinorelbine 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Granulocyte Colony-Stimulating Factor × Other solid neoplasm × Clear all
NCT00110110 2024-04-17

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma

The Hospital for Sick Children

Phase 2 Unknown
71 enrolled
Other solid neoplasm

Retinoblastoma

NCT01783535 2024-04-16

Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma

St. Jude Children's Research Hospital

Phase 2 Active not recruiting
174 enrolled
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡